Figure 7From: C2Maps: a network pharmacology database with comprehensive disease-gene-drug connectivity relationshipsBreast cancer case study for drug pharmacological effect evaluation with C2Maps. (a) Distribution of directionality categories for breast cancer; (b) A drug-target subnetwork with directionality information specific for Tamoxifen; (c) Drug effect evaluation for Tamoxifenon breast cancer subtype - luminal A; (d) Drug effect evaluation for Tamoxifenon breast cancer subtype - basal-like; (e) A drug-target subnetworkwith the directionality information specific for Plicamycin; (f) Drug effect evaluation for Plicamycinon breast cancer subtype - luminal A.Back to article page